Proud to join Shannon M MacDonald as a plaintiff in this critical, national legal effort spearheaded by Pacific Legal 🗡⚖️. State restrictions on inter-state telehealth criminalize consultations between patients and out-of-state specialists. These laws violate cancer patients' core 1st

🧠Most Medicare pts received long course #radiation for primary brain tumors, with hypofractionated RT⬆️in hospital-affiliated centers. Given potential QOL & spending benefits of shorter tx in older pts, this may represent a gap in high value care. #btsm
jnccn.org/configurable/c…

📢We are overjoyed to announce that Dr Himanshu Nagar will be joining Memorial Sloan Kettering Cancer Center this summer as our Genitourinary Cancer Disease site leader. Dr Nagar is a compassionate clinician & innovative researcher. We are excited to see where he leads our GU #radonc team!

We need to change the paradigm in LA-HNSCC. Adding anti-PD1/PDL1 concurrently or adjuvantly has not worked. I think the solution will come with better biomarkers, changing radiation dosing, and rationally applied therapy sequencing. thelancet.com/journals/lanon…

This is huge

Proud of my brilliant co-residents — Chris Jackson, MD MS and Trisha Santos, MD, MS — for their ASCO Annual Meeting Merit Awards!

Great trial. This has been SOC Memorial Sloan Kettering Cancer Center for some time now in the newly diagnosed setting. Happy to see it supported by level 1 evidence.

Great pleasure/honor to be invited as Visiting Prof. and give Grand Rounds in Rad Onco, Memorial Sloan Kettering Cancer Ct to talk about optimizing local therapy in the era of immunotherapy. Great discussions with brilliant colleagues/friends in person and Zoom. Nancy Lee

#ICHNO24

Honoured to deliver the Keynote lecture on ctDNA in #headandneckcancer

Thanks to great colleagues Eleni Rettig Linda Chen Nancy Lee who were generous to share their data and insights on the trials using ctDNA guided treatment and FU in #HPVOPSCC

Much to be learnt!

Fantastic idea! The reduction in normal tissue receiving higher dose is markedly reduced with a 0 mm CTV70 margin.

Some centers (many?) already have this policy. The more data published on lack of marginal failure, the better.

Endpoints for DAHANCA 41?

David Sher Love trials that ask fundamental radiation-related questions. MSKCC Head and Neck (@imrtlee Nadeem Riaz C. Jillian Tsai, MD, PhD Yao Yu Kaveh Zakeri Linda Chen) doesn't use CTV 70s. Nice to see data in support of this.

New in IJROBP - The Red Journal by #proton fellow Dr Irini Youssef & Nancy Lee: There was a difference in biologic dose in high/low-uptake regions on 3-mo post-IMPT. However, this did not translate to PET uptake in the CTVp at 3 & 6-mo follow-up between IMPT & IMRT. #hncsm
sciencedirect.com/science/articl…

The best part of conferencing is seeing your friends! #ACRO2024 #WeWhoCurie

Inspiring having Nancy Lee at Mass General Cancer Center Women in Cancer Grand Rounds‼️

Dr. Lee hit it out of the park (⚾️😊) with her talk on #precisiononcology for HPV+ HNSCC. Cool story & clinical concept to de-escalate #radiotherapy 💪🙏

➡️ascopubs.org/doi/abs/10.120…

#radbio #radonc

New 📰 from Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Medical Physics on the implementation & accuracy evaluation of the auto-segmentation algorithm, “Masked Image modeling using the vision Transformers (SMIT),” for neck nodal metastases on MR images in #OPSCC #HNCSM pts.
📍academic.oup.com/bjrai/article/…

Melvin LK CHUA Michael Mejia C. Jillian Tsai, MD, PhD Agree! Seems like we are going through the same growing pains with hpv as ebv. Changing mgmt on hpv cfdna still seems challenging based on Linda Chen and Nancy Lee work

☢️LINAC-based adaptive #radiotherapy (ART) for #headandneckCancer reduced doses to critical salivary structures & oral cavity. Automated CBCT tracking provided anatomic change info that may aid identifying which patients may be good ART candidates. #hncsm
sciencedirect.com/science/articl…

So many of my favorite people in one photo! 🤩

One of my favourite talks from #ASTRO22 and now the paper has dropped in IJROBP - The Red Journal from Nancy Lee Memorial Sloan Kettering Radiation Oncology H&N #hncsm #RadOnc team.

AI-enabled offline CT-adaptive XRT on conventional LINAC.

W/ better CBCT (eg HyperSight) potential benefit may even ⬆️

shorturl.at/deGY6